Product
Autologous Natural Killer Cell-like CTLs
1 clinical trial
21 indications
Indication
Fallopian Tube CancerIndication
Ovarian CancerIndication
Primary Peritoneal CancerIndication
Ovarian Cancer, Stage IIA AJCC v8Indication
Primary Peritoneal Cancer AJCC v8Indication
Ovarian Cancer, Stage IIB AJCC v8Indication
Stage III Ovarian Cancer AJCC v8Indication
Stage IIIA1 Ovarian Cancer AJCC v8Indication
Ovarian Cancer, Stage IIIB (AJCC v8)Indication
Fallopian Tube Cancer, Stage IV, AJCC v8Indication
Stage IV Ovarian CancerIndication
Primary Peritoneal Cancer (Stage IV)Indication
Stage IV Fallopian Tube Cancer AJCC v8Indication
Stage IV Ovarian Cancer AJCC v8Indication
Ovarian Cancer Stage IVB AJCC v8Clinical trial
A Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian CancerStatus: Withdrawn, Estimated PCD: 2025-12-01